These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
171 related articles for article (PubMed ID: 28744693)
21. Fluvastatin inhibits AGE-induced cell proliferation and migration via an ERK5-dependent Nrf2 pathway in vascular smooth muscle cells. Hwang AR; Han JH; Lim JH; Kang YJ; Woo CH PLoS One; 2017; 12(5):e0178278. PubMed ID: 28542559 [TBL] [Abstract][Full Text] [Related]
22. Identifying molecular features that distinguish fluvastatin-sensitive breast tumor cells. Goard CA; Chan-Seng-Yue M; Mullen PJ; Quiroga AD; Wasylishen AR; Clendening JW; Sendorek DH; Haider S; Lehner R; Boutros PC; Penn LZ Breast Cancer Res Treat; 2014 Jan; 143(2):301-12. PubMed ID: 24337703 [TBL] [Abstract][Full Text] [Related]
23. miRNA-205 targets VEGFA and FGF2 and regulates resistance to chemotherapeutics in breast cancer. Hu Y; Qiu Y; Yagüe E; Ji W; Liu J; Zhang J Cell Death Dis; 2016 Jun; 7(6):e2291. PubMed ID: 27362808 [TBL] [Abstract][Full Text] [Related]
24. Bone-Bound Bisphosphonates Inhibit Proliferation of Breast Cancer Cells. Park YE; Bava U; Lin JM; Cornish J; Naot D; Reid IR Calcif Tissue Int; 2019 Nov; 105(5):497-505. PubMed ID: 31324954 [TBL] [Abstract][Full Text] [Related]
25. Fluvastatin mediated breast cancer cell death: a proteomic approach to identify differentially regulated proteins in MDA-MB-231 cells. Kanugula AK; Dhople VM; Völker U; Ummanni R; Kotamraju S PLoS One; 2014; 9(9):e108890. PubMed ID: 25268751 [TBL] [Abstract][Full Text] [Related]
26. Screening critical genes associated with malignant glioma using bioinformatics analysis. Xu Y; Wang J; Xu Y; Xiao H; Li J; Wang Z Mol Med Rep; 2017 Nov; 16(5):6580-6589. PubMed ID: 28901452 [TBL] [Abstract][Full Text] [Related]
27. miR-1 Inhibits Cell Growth, Migration, and Invasion by Targeting VEGFA in Osteosarcoma Cells. Niu J; Sun Y; Guo Q; Niu D; Liu B Dis Markers; 2016; 2016():7068986. PubMed ID: 27777493 [TBL] [Abstract][Full Text] [Related]
28. Agonists and knockdown of estrogen receptor β differentially affect invasion of triple-negative breast cancer cells in vitro. Schüler-Toprak S; Häring J; Inwald EC; Moehle C; Ortmann O; Treeck O BMC Cancer; 2016 Dec; 16(1):951. PubMed ID: 28003019 [TBL] [Abstract][Full Text] [Related]
29. Fluvastatin does not prevent the acute-phase response to intravenous zoledronic acid in post-menopausal women. Thompson K; Keech F; McLernon DJ; Vinod K; May RJ; Simpson WG; Rogers MJ; Reid DM Bone; 2011 Jul; 49(1):140-5. PubMed ID: 21047568 [TBL] [Abstract][Full Text] [Related]
30. Propofol induces proliferation partially via downregulation of p53 protein and promotes migration via activation of the Nrf2 pathway in human breast cancer cell line MDA-MB-231. Meng C; Song L; Wang J; Li D; Liu Y; Cui X Oncol Rep; 2017 Feb; 37(2):841-848. PubMed ID: 28035403 [TBL] [Abstract][Full Text] [Related]
31. Validation of a network-based strategy for the optimization of combinatorial target selection in breast cancer therapy: siRNA knockdown of network targets in MDA-MB-231 cells as an in vitro model for inhibition of tumor development. Tilli TM; Carels N; Tuszynski JA; Pasdar M Oncotarget; 2016 Sep; 7(39):63189-63203. PubMed ID: 27527857 [TBL] [Abstract][Full Text] [Related]
32. [Effect of TCF21 on proliferation, migration and vascular production of breast cancer cells]. Li PW; Wang HY; Xu LL Zhonghua Bing Li Xue Za Zhi; 2019 Apr; 48(4):307-311. PubMed ID: 30955268 [No Abstract] [Full Text] [Related]
33. Herb-sourced emodin inhibits angiogenesis of breast cancer by targeting VEGFA transcription. Zou G; Zhang X; Wang L; Li X; Xie T; Zhao J; Yan J; Wang L; Ye H; Jiao S; Xiang R; Shi Y Theranostics; 2020; 10(15):6839-6853. PubMed ID: 32550907 [TBL] [Abstract][Full Text] [Related]
34. Osteopontin Regulates VEGFA and ICAM-1 mRNA Expression in Breast Carcinoma. Ortiz-Martínez F; Sanmartín E; Pomares-Navarro E; Pérez-Balaguer A; Andrés L; Sánchez-Payá J; Aranda FI; Lerma E; Peiró G Am J Clin Pathol; 2015 Jun; 143(6):812-22. PubMed ID: 25972323 [TBL] [Abstract][Full Text] [Related]
35. Identification of breast cancer hub genes and analysis of prognostic values using integrated bioinformatics analysis. Fang E; Zhang X Cancer Biomark; 2017 Dec; 21(1):373-381. PubMed ID: 29081411 [TBL] [Abstract][Full Text] [Related]
36. [Study on effect of naringenin in inhibiting migration and invasion of breast cancer cells and its molecular mechanism]. Sun Y; Gu J Zhongguo Zhong Yao Za Zhi; 2015 Mar; 40(6):1144-50. PubMed ID: 26226761 [TBL] [Abstract][Full Text] [Related]
37. Antimetastatic effect of fluvastatin on breast and hepatocellular carcinoma cells in relation to SGK1 and NDRG1 genes. Salis O; Okuyucu A; Bedir A; Gör U; Kulcu C; Yenen E; Kılıç N Tumour Biol; 2016 Mar; 37(3):3017-24. PubMed ID: 26419593 [TBL] [Abstract][Full Text] [Related]
38. Investigating the therapeutic potential and mechanism of curcumin in breast cancer based on RNA sequencing and bioinformatics analysis. Wang R; Li J; Zhao Y; Li Y; Yin L Breast Cancer; 2018 Mar; 25(2):206-212. PubMed ID: 29139094 [TBL] [Abstract][Full Text] [Related]
39. Insulin like growth factor binding protein-7 reduces growth of human breast cancer cells and xenografted tumors. Amemiya Y; Yang W; Benatar T; Nofech-Mozes S; Yee A; Kahn H; Holloway C; Seth A Breast Cancer Res Treat; 2011 Apr; 126(2):373-84. PubMed ID: 20464481 [TBL] [Abstract][Full Text] [Related]
40. Transcriptional regulation of VEGFA expression in T-regulatory cells from breast cancer patients. Kajal K; Bose S; Panda AK; Chakraborty D; Chakraborty S; Pati S; Sarkar T; Dhar S; Roy D; Saha S; Sa G Cancer Immunol Immunother; 2021 Jul; 70(7):1877-1891. PubMed ID: 33394094 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]